首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1477915

新生兒篩檢市場- 按產品類型（儀器、消耗品）、技術（串聯質譜、血氧測定、酶檢測、DNA 檢測）、測試類型（乾血斑、聽力篩檢、CCHD）、最終用途- 全球預測、 2024 - 2032

Newborn Screening Market - By Product Type (Instruments, Consumables), Technology (Tandem Mass Spectrometry, Oximetry, Enzyme-Based Assays, DNA Assays), Test Type (Dried Blood Spot, Hearing Screening, CCHD), End-use - Global Forecast, 2024 - 2032

出版日期: 2024年02月22日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

受政府加強早期疾病檢測舉措、醫療保健專業人員和家長意識不斷增強以及新生兒篩檢測試對高品質耗材需求不斷成長的推動，全球新生兒篩檢市場規模在2024 年至2032 年期間將以7.7 % 的複合年成長率成長。

據世界衛生組織稱，隨著新生兒和 5 歲以下兒童死亡率的下降，先天性疾病在這些死亡中所佔的比例越來越大。隨著全球越來越多的嬰兒出生時患有先天性疾病，迫切需要早期發現和干涉，以減輕對其健康和福祉的潛在影響。

這些疾病涵蓋範圍廣泛，從代謝紊亂到先天性心臟缺陷、脊髓性肌肉萎縮和各種遺傳異常。隨著人們越來越認知到早期診斷對於改善臨床結果和降低醫療成本的重要性，醫療保健系統正在將更多資源投入到新生兒篩檢計畫中，導致對篩檢測試和相關服務的需求激增。

新生兒篩檢市場根據產品類型、技術、測試類型、最終用途和地區進行分類。

由於消耗品在新生兒篩檢過程中發揮關鍵作用，因此消耗品細分市場將在 2024 年至 2032 年間大幅成長，涵蓋採血設備、試劑和檢測試劑盒等一系列產品。隨著全球新生兒篩檢測試數量的不斷增加，對高品質耗材的需求不斷成長，以確保結果準確可靠。新生兒篩檢市場的製造商正在專注於開發創新耗材，以提高檢測效率，同時保持嚴格的品質標準。此外，乾血斑（DBS）技術的出現簡化了樣本採集和運輸，從而促進了細分市場的成長。

到2032 年，血氧測定領域的新生兒篩檢市場佔有率將獲得顯著成長，因為脈搏血氧計通常用於篩檢新生兒先天性心臟病和其他呼吸系統疾病，從而實現早期發現和及時干預。將血氧測定法納入新生兒篩檢方案提高了危重先天性心臟病 (CCHD) 的檢出率，從而改善臨床結果並降低醫療成本。此外，隨著醫療機構升級其篩檢基礎設施，預計細分市場將進一步成長。

由於該地區對預防性醫療保健的日益重視和遺傳性疾病盛行率的不斷上升，亞太地區新生兒篩檢產業將在 2032 年呈現出可觀的成長速度。中國、印度和日本等國政府旨在擴大新生兒篩檢計畫和改善醫療基礎設施的措施激增。此外，醫療保健支出的增加以及家長對早期疾病檢測重要性的認知不斷提高，正在推動該地區的市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 遺傳和代謝疾病的發生率增加
  - 技術進步
  - 醫療保健專業人員和家長的意識不斷提高
  - 出生率上升和人口成長
- 產業陷阱與挑戰
  - 世界各地新生兒篩檢程序缺乏統一性
  - 嚴格的監理政策
成長潛力分析
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

主要趨勢
儀器
- 乾血點打孔器
- 聽力篩檢設備
- 分析儀
- 電泳裝置
- 脈搏血氧儀
- 其他儀器
耗材

第 6 章：市場估計與預測：按技術分類，2018 年 - 2032 年

主要趨勢
串聯質譜法
血氧測定法
基於酵素的測定
DNA檢測
其他技術

第 7 章：市場估計與預測：按測試類型，2018 - 2032

主要趨勢
乾血斑
聽力篩檢
嚴重先天性心臟病（CCHD）
其他測試類型

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院
診斷中心
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Masimo Corporation
Medtronic plc
Natus Medical Incorporated
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Waters Corporation

簡介目錄

Product Code: 8223

Global Newborn Screening Market Size will grow at 7.7% CAGR during 2024-2032, driven by increasing government initiatives for early disease detection, growing awareness among healthcare professionals and parents, and rising demand for high-quality consumables in newborn screening tests.

According to WHO, as neonatal and under-5 mortality rates decrease, congenital disorders represent a growing proportion of these deaths. With an increasing number of infants being born with congenital conditions globally, there's a pressing need for early detection and intervention to mitigate the potential impact on their health and well-being.

These disorders encompass a wide spectrum, ranging from metabolic disorders to congenital heart defects, spinal muscular atrophy, and various genetic abnormalities. As awareness grows regarding the significance of early diagnosis in improving clinical outcomes and reducing healthcare costs, healthcare systems are investing more resources into newborn screening programs, resulting in a surge in demand for screening tests and related services.

The Newborn Screening Market is classified based on product type, technology, test type, end-use, and region.

Consumables segment will grow substantially between 2024 and 2032, owing to their pivotal role in the newborn screening process, encompassing a range of products such as blood collection devices, reagents, and assay kits. With the increasing volume of newborn screening tests conducted globally, there is a growing demand for high-quality consumables to ensure accurate and reliable results. Manufacturers in the newborn screening market are focusing on developing innovative consumables that enhance testing efficiency while maintaining stringent quality standards. Furthermore, the advent of dried blood spot (DBS) technology has simplified sample collection and transportation, thereby inducing segment growth.

The Newborn Screening Market Share from the oximetry segment will garner noticeable gains through 2032, as pulse oximeters are commonly used to screen for congenital heart defects and other respiratory conditions in newborns, enabling early detection and timely intervention. The integration of oximetry into newborn screening protocols has improved the detection rate of critical congenital heart diseases (CCHD), leading to better clinical outcomes and reduced healthcare costs. Moreover, as healthcare facilities upgrade their screening infrastructure, further segment growth is anticipated.

Asia Pacific Newborn Screening Industry will exhibit a decent growth rate through 2032, driven by the increasing emphasis on preventive healthcare and the growing prevalence of genetic disorders in the region. Countries such as China, India, and Japan are witnessing a surge in government initiatives aimed at expanding newborn screening programs and improving healthcare infrastructure. Moreover, rising healthcare expenditure and greater awareness among parents regarding the importance of early disease detection are fueling market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of genetic and metabolic disorders
  - 3.2.1.2 Advancements in technology
  - 3.2.1.3 Rising awareness among healthcare professionals and parents
  - 3.2.1.4 Rising birth rates and population growth
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of uniformity of newborn screening procedure around the world
  - 3.2.2.2 Stringent regulatory polices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
- 5.2.1 Dried blood spot puncher
- 5.2.2 Hearing screening devices
- 5.2.3 Analyzers
- 5.2.4 Electrophoresis unit
- 5.2.5 Pulse oximetry
- 5.2.6 Other instruments
5.3 Consumables

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Tandem mass spectrometry
6.3 Oximetry
6.4 Enzyme-based assays
6.5 DNA assays
6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Dried blood spot
7.3 Hearing screening
7.4 Critical congenital heart defect (CCHD)
7.5 Other test types

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic centers
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa